Ping Lei
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 5%
- Immunotherapy and Immune Responses
- Macrophage Migration Inhibitory Factor
Papers in
-
- RNA Interference and Gene Delivery 11
- Immunology 28
- Immunotherapy and Immune Responses 10
- Immune Cell Function and Interaction 7
- Co-authors
- Stephen Safe (16 shared papers)Indira Jutooru (4 shared papers)Sudhakar Chintharlapalli (7 shared papers)Gayathri Chadalapaka (3 shared papers)Maen Abdelrahim (8 shared papers)Guanxin Shen (34 shared papers)Huifen Zhu (35 shared papers)Zhenghao Wu (3 shared papers)
- Journals
- Frontiers in Immunology (8 papers)Molecular Cancer Therapeutics (6 papers)PLoS ONE (5 papers)International Immunopharmacology (3 papers)Frontiers in Neurology (3 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Ping Lei
126 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 140
- Cancer Research 361
- Immunology 496
- Molecular Biology 1.2k
- Molecular Medicine 82
- Toxicology 55
Countries citing papers authored by Ping Lei
This map shows the geographic impact of Ping Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Lei more than expected).
Fields of papers citing papers by Ping Lei
This network shows the impact of papers produced by Ping Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Lei. The network helps show where Ping Lei may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping Lei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 133 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 179 | |
| 2 | 2010 | 164 | |
| 3 | 2007 | 150 | |
| 4 | 2011 | 149 | |
| 5 | 2022 | 80 | |
| 6 | 2018 | 80 | |
| 7 | 2012 | 78 | |
| 8 | 2009 | 77 | |
| 9 | 2010 | 74 | |
| 10 | 2015 | 70 | |
| 11 | 2008 | 55 | |
| 12 | 2011 | 55 | |
| 13 | 2020 | 53 | |
| 14 | 2010 | 51 | |
| 15 | 2010 | 47 | |
| 16 | 2016 | 45 | |
| 17 | 2023 | 44 | |
| 18 | 2019 | 44 | |
| 19 | 2008 | 41 | |
| 20 | 2012 | 37 |
About Ping Lei
Ping Lei is a scholar working on Molecular Biology, Immunology, Oncology, Epidemiology and Genetics, having authored 133 papers that have together received 3.0k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (11 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Immunotherapy and Immune Responses (10 papers), Vestibular and auditory disorders (9 papers), Endoplasmic Reticulum Stress and Disease (9 papers), Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (7 papers) and Virus-based gene therapy research (6 papers). The work is most often cited by research in Cancer Research (361 citations), Immunology (496 citations), Molecular Biology (1.2k citations), Molecular Medicine (82 citations) and Toxicology (55 citations). Ping Lei has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Stephen Safe, Indira Jutooru, Sudhakar Chintharlapalli, Gayathri Chadalapaka, Maen Abdelrahim, Guanxin Shen, Huifen Zhu, Zhenghao Wu, Zhenxiong Zhang and Zehua Lei. Their work appears in journals such as Frontiers in Immunology, Molecular Cancer Therapeutics, PLoS ONE, International Immunopharmacology and Frontiers in Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.